Escientia Life Sciences
Krishnakanth Kotaru has extensive experience in regulatory sciences within the pharmaceutical industry. Krishnakanth has held leadership positions at companies such as Escientia Life Sciences, where Krishnakanth is responsible for strategizing the business from a regulatory perspective. Krishnakanth has also worked at Hetero and Dr. Reddy's Laboratories Limited, where Krishnakanth managed global regulatory affairs and quality assurance. Krishnakanth holds a Master's degree in Analytical Chemistry and an MBA in Business, Management, Marketing, and Related Support Services. Krishnakanth has also completed executive learning in Leadership & Change Management from XLRI Jamshedpur.
This person is not in any offices
Escientia Life Sciences
Modern science and engineering are revolutionizing the way medicines are made. We are at the cutting-edge of continuous processing, green chemistry, and increased reliability in pharmaceutical manufacturing. Escientia is a premier American technology-oriented manufacturing partner to the largest and most innovative pharma and biotech companies, and governments seeking to secure critical supply chains. Escientia was founded in 2007 by Dr. Yadagiri Pendri, Chairman and Chief Executive Officer, who has led the company to become a preferred partner to the global innovative pharmaceutical industry over the last 15 years. The company's co-founder and President, Kiran Pendri, leads Escientia's efforts to constantly expand its capabilities and capacity. Escientia's global headquarters and research laboratories are in South Windsor, Connecticut, in the United States. Additionally, Escientia has a development hub in Hyderabad, Telangana, and one of the world's most modern pharmaceutical manufacturing parks, located in Vizag, Andhra Pradesh, both in India.